Lorenzo Lorusso

Lorenzo Lorusso, MD, is the Head of the Multiple Sclerosis (SM)/Amyotrophic Lateral Sclerosis (ALS) Centre and a Consultant Neurologist at Mellino Mellini Hospital, Chiari-Brescia, Italy. He serves on the Scientific Committee of Associazione Malati di CFS onlus, a patient advocacy group for chronic fatigue syndrome in Pavia, Italy and on the scientific committee for creating recommendations for the Italian National Agency for Health Regional Service (AGENAS) of the Italian National Institute of Health on CFS/ME.

EUROMENE
Dr. Lorusso is a member of the Working Group on dissemination and exploitation, patient involvement, digitalisation on behalf of the EUROMENE, a European Union COST Action CA15111 not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Notable studies

 * 2004, Chronic fatigue syndrome: a review (Abstract)
 * 2006, A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles.
 * 2009, Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome.
 * 2009, Immunological aspects of chronic fatigue syndrome (Abstract)
 * 2010, Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An Update (Full Text)
 * 2015, Chronic fatigue syndrome: Features of a population of patients from northern Italy (Full Text)
 * 2016, Genetic evaluation of AMPD1, CPT2, and PGYM metabolic enzymes in patients with chronic fatigue syndrome (Full Text)
 * 2017, XMRV and Public Health: The Retroviral Genome Is Not a Suitable Template for Diagnostic PCR, and Its Association with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Appears Unreliable (Full Text)
 * 2018, Cardiovascular characteristics of chronic fatigue syndrome (Full Text)

Online presence

 * PubMed
 * EUROMENE CV